| abstract |
The invention relates to a group of phenylpiperazine derivatives with a double mode of action: inhibition of serotonin reabsorption and partial agonism of dopamine-D2 receptors; The invention also relates to the use of a compound described in this description for the manufacture of a medicament that has a beneficial effect; the compounds have the general formula (1): (see formula (1)) where the symbols have the meanings given in the specification, and the tautomers, stereoisomers and N-oxides thereof, as well as the salts, hydrates and solvates pharmacologically acceptable of said compounds of formula (1) and their tautomers, stereoisomers and N-oxides. |